project id: TCGA-HNSC; case submitter id: TCGA-IQ-7631; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.24; rna integrity number: 8.4; age at index: 60; days to birth: -22151; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22151; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1172.0; icd 10 code: C06.0; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cheek mucosa; synchronous malignancy: No; tissue or organ of origin: Cheek mucosa; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: No; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; years smoked: 30.0; is ffpe: false; weight: 49.0; composition: Not Reported; days to sample procurement: 0; oct embedded: No; portion submitter id: TCGA-IQ-7631-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 60.0;